Robert Rouse
Company: CSL Behring
Job title: Head of Market Access
Seminars:
Chair’s Closing Remarks 4:15 pm
day: Conference Day Two
Chair’s Opening Remarks 8:50 am
day: Conference Day One
Chair’s Closing Remarks 5:00 pm
day: Conference Day One
A Comprehensive Approach to Understanding, Evaluating & Planning for the Commercialization of Transformative Cell & Gene Therapies to Gain Insights into the Challenges Faced, Forming a Robust Foundation for Strat 1:01 pm
This session will help you understand, evaluate and plan for the commercialization of cell and gene therapies in the healthcare landscape. It encompasses financial considerations, patient outcome monitoring, commercial adoption, addressing challenges, ensuring patient coverage, and strategizing for future therapy delivery. Join to: Gain insights into the evolving landscape of public payment dynamics following cell…Read more
day: Pre-Conference Workshop Day
Chair’s Opening Remarks 8:50 am
day: Conference Day Two